EurekAlert (press release)Mass. Eye and Ear performs first FDA-approved gene therapy procedure for inherited diseaseEurekAlert (press release)(BOSTON) – Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval… Continue reading
CapeGazette.comImmunotherapy shows success in treating cancerCapeGazette.comCancer cells are smart, so they put up a shield around themselves and work hard to survive. In order to kill them, cancer treatments have to be smarter. Research being done wit… Continue reading
New York Daily NewsStem cell therapy restores sight in two patientsNew York Daily NewsTwo patients in the UK with advanced cases of age-related macular degeneration regained enough vision to be able to read again thanks to a new stem-cell therapy. Both… Continue reading
UC BerkeleyBrewing hoppy beer without the hopsUC BerkeleyDenby came to UC Berkeley to work on sustainable transportation fuels with Jay Keasling, a pioneer in the field of synthetic biology and a professor of chemical and biomolecular engineering. The … Continue reading
Harvard School of Engineering and Applied Sciences |
Novartis taps Harvard tech to advance cancer immunotherapy efforts
BioPharma Dive Swiss pharma Novartis AG is teaming up with researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS), the Wyss Institute and the Dana-Farber Institute on a project to further develop the academic group’s … Novartis, Harvard, Dana-Farber Partner on Biomaterial for Cancer ImmunotherapiesGenetic Engineering & Biotechnology News Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by NovartisPR Newswire (press release) SEAS-developed cancer immunotherapies to be commercialized by …Harvard School of Engineering and Applied Sciences GlobeNewswire (press release) all 12 news articles » |